Search for: "Dial v. T " Results 641 - 660 of 681
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
29 Aug 2008, 1:25 pm
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: CAFC sets strict standards to establish inequitable conduct: Star Scientific v R J Reynolds Tobacco: (Hal Wegner), (Maryland Intellectual Property Law Blog), (Patent Prospector), (Patent Docs), (Patently-O), (more from Patently-O), (Philip Brooks), (Law360), (I/P Updates), Safe harbour ruling in Io v Veoh could help YouTube in Viacom… [read post]
23 Jul 2008, 10:23 am
So while the New Jersey Supreme Court can't change the U.S. [read post]
20 Jun 2008, 8:07 am
– Marks & Clerk Biotechnology Report 2008: (IP finance), Pfizer and Daiichi-Sankyo’s bidding for Ranbaxy: (IP ThinkTank), (IAM), (Managing Intellectual Property), (GenericsWeb), Cutting Edge Information study reveals 53% of pharma patents approach expiration before litigation strategies are implemented: (Peter Zura's 271 Patent Blog), Quanta and agricultural biotechnology: (Holman’s Biotech IP Blog), Breakthough by WHO will give poor countries better access… [read post]
16 Apr 2008, 1:44 am
You just can't get enough Lord Mansfield. [read post]
14 Apr 2008, 11:34 am
Dial, No. 06-5519 A sentence for drug- and firearm-related offenses is affirmed where there was a nexus between defendant's flight on a particular date and his conviction for conspiracy to possess with intent to distribute methamphetamine, and the other factors required for an enhancement under U.S.S.G. section 3C1.2 for reckless endangerment during flight were satisfied. [read post]
1 Apr 2008, 7:29 am
See alsoFurther comments on Feb. 8 arguments in Tafas v. [read post]
23 Mar 2008, 10:33 am
Civ. 99, 19/11/07, V. [read post]
22 Mar 2008, 2:00 am
: (IPBiz),US: Two remaining challenged WARF embryonic stem cell patents upheld in ex parte reexamination: (Holman's Biotech IP Blog), Pharma & Biotech - ProductsAricept (Donepezil) – USV wins appeal against USPTO decision: (Spicy IP),Celerex (Celecoxib) – CAFC decision in Celebrex patents dispute between Pfizer and Teva will cut patent term by one and a half years: (Patent Baristas), Inersan – Ranbaxy in-licenses Inersan to CD Pharma to market in India and… [read post]
20 Mar 2008, 8:49 pm
One important factor contributing to the change is attributable to State Street Bank and Trust Co. v. [read post]
16 Dec 2007, 7:21 pm
Correctamente, la CNDC define un único mercado relevante, con independencia: de la tecnología empleada, en la medida en que dial-up, ADSL y Cablemódem son consideradas como sustitutivas por parte del usuario ysatisfacen las mismas necesidadesEntonces, al juntar las tres Fs (Fibertel 11,6 %, Flash 14,6 %, Fullzero 6,3 %) el Grupo Clarín tendrá el 32,5 % del… [read post]